17.18BMarket Cap54.16P/E (TTM)
54.210High53.310Low403.76KVolume53.560Open54.440Pre Close21.69MTurnover0.24%Turnover Ratio54.16P/E (Static)317.28MShares55.18952wk High19.45P/B9.17BFloat Cap41.25852wk Low0.20Dividend TTM169.31MShs Float71.247Historical High0.37%Div YieldTTM1.65%Amplitude26.110Historical Low53.721Avg Price1Lot Size
Bentley Systems Stock Forum
8/15 watchlist ⚡️
ColumnsUS Top Gap Ups and Downs on 11/10: BILL, MTCH, ZS, DOCU, BNTX and More
Gap Ups
1. $Fair Isaac(FICO.US)$ - up 15.95%
2. $NICE Ltd(NICE.US)$ - up 15.35%
3. $BILL Holdings(BILL.US)$ - up 8.69%
4. $Datadog(DDOG.US)$ - up 7.05%
5. $Coupang(CPNG.US)$ - up 6.21%
6. $Match group(MTCH.US)$ - up 5.98%
7. $Zscaler(ZS.US)$ - up 5.97%
8. $ServiceNow(NOW.US)$ - up 5...
ColumnsTop upgrades and downgrades on 5/20
• $Banco De Chile(BCH.US)$ : Santander Upgrades to Outperform from Neutral - PT $25
• $Comerica(CMA.US)$ : Baird Upgrades to Outperform from Neutral - PT $85
• $Mirati Therapeutics(MRTX.US)$ : Guggenheim Upgrades to Buy from Neutral - PT $115
• $Ollie's Bargain Outlet(OLLI.US)$ : BofA Securities Upgrades to Buy from Underperform - PT $75 (from $39)
• $Trex Co.(TREX.US)$ : Exane Upgrades to Neutral from Underperform - PT $75
Downgrades
• $Ferguson(FERG.US)$ : Exane D...
ColumnsIPO Recap: Sports betting and data firm Sportradar started trading
The Post Labor Day IPO storm is coming this week and several large IPOs will be listed.
On the last trading day, there was one traditional IPO filed and one new stock officially listed for trading.
MiNK Therapeutics, founded in 2017, is a Phase 1 biotech developing allogenic T cell therapies for cancer and immune-mediated diseases.
MiNK Therapeutics' lead program, AGENT-797, is an allogeneic, off-the-shelf, invariant natural killer T (iNKT) cell therapy targeting cancer and other immune-mediated diseases. The company claims that iNKT cells naturally home to tissues, aid clearance of tumors and infected cells, and suppress graft-versus-host disease. AGENT-797 is currently conducting a Phase 1 trial in multiple myeloma patients that is expected to report top-line data in the fourth quarter of 2021.
$Sportradar Group AG(SRAD.US)$ , founded in 2001, is a sports betting and data firm. It provides mission-critical software, data and content via subscription, and revenue share arrangements to betting operators, sports leagues, and media companies.
Sportradar offers robust and fully integrated sports data and technology platforms. It serves as a critical data infrastructure and content layer to the sports betting and media industries. On top of that infrastructure layer, it has built advanced and comprehensive software offerings.
Sportradar leads on the breadth of events coverage for sports data and odds. It collects over 1.2 billion live data points per year from over 600,000 events in 37 sports.
Related:
IPO-pedia: Sports betting and data firm Sportradar plans New York IPO
$Bentley Systems(BSY.US)$ is a software development company that supports the professional needs of those responsible for creating and managing the world’s infrastructure, including roadways, bridges, airports, skyscrapers, and industrial and power plants, as well as utility networks.
Bentley delivers solutions for the entire lifecycle of the infrastructure asset, tailored to the needs of the various professions – the engineers, architects, geospatial professionals, planners, contractors, fabricators, IT managers, operators and maintenance engineers – who will work on and work with that asset over its lifetime.
As of September 15th, it has a market cap of $19.48 billion, with the listed to date gain of 214.32%.
No comment yet